CXCL13: a common target for immune-mediated inflammatory diseases
Lu Hui1, Ye Li1, Meng-Ke Huang1
1Department of Laboratory Medicine, West China Second University Hospital, and Key Laboratory of Obstetric and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, Sichuan University, No. 20, Section 3, Renmin Road South, Chengdu, 610041, Sichuan, People's Republic of China.
Chemokine CXCL13 regulates lymphoid organ development and immune responses. Its ectopic expression in disease drives inflammation and ectopic lymphoid structures, offering therapeutic targets.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- CXCL13 is a chemokine crucial for secondary lymphoid organ development.
- Its role extends to regulating inflammatory responses in various diseases.
- CXCL13 expression differs between healthy and disease states.
Purpose of the Study:
- To review the sources of CXCL13 in different physiological and pathological conditions.
- To elucidate the regulatory mechanisms of CXCL13 in immune-mediated inflammatory diseases.
- To provide insights for targeting CXCL13 in disease treatment.
Main Methods:
- Literature review focusing on CXCL13 expression and function.
- Analysis of CXCL13 sources in healthy versus diseased hosts.
- Examination of CXCL13's role in immune cell migration and ectopic lymphoid organogenesis.
Main Results:
- CXCL13 is produced by stromal cells/follicular T cells in health, and by peripheral T cells/macrophages ectopically in disease.
- Ectopic CXCL13 expression promotes immune cell infiltration and inflammatory factor production.
- Ectopic CXCL13 is a key driver of ectopic lymphoid structure formation.
Conclusions:
- Understanding CXCL13 sources and regulation is vital for immune-mediated inflammatory diseases.
- Targeting ectopic CXCL13 offers a potential therapeutic strategy.
- Further research into CXCL13 mechanisms can lead to novel treatments.
More Related Videos
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
The JAK-STAT Signaling Pathway


